Why is Suven Life Scie. falling/rising?

As of 02-Jul, Suven Life Sciences Ltd is experiencing a decline in its stock price, currently at Rs 248.95, down by Rs 7.55 or 2.94%. Today's price summary indicates that the stock has underperformed its sector by 3.02% and has fallen after six consecutive days of gains, touching an intraday low of Rs 244. Despite trading above its moving averages, the company faces significant challenges, including operating losses and weak long-term fundamental strength, with net sales declining at an annual rate of 49.94% over the last five years. Additionally, the company has reported negative results for the last three consecutive quarters, which has contributed to a risky trading environment, as evidenced by a negative EBITDA and a falling participation from institutional investors.
In the broader market context, Suven Life Sciences Ltd has outperformed the benchmark Sensex in the long term, with a year-to-date return of 93.51% compared to the Sensex's 6.75%. However, in the short term, the stock's recent performance has not matched the benchmark, as it has only gained 4.84% over the past week, while the Sensex has increased by 0.79%. This disparity, combined with the company's deteriorating financial health and reduced institutional interest, suggests that while the stock has shown strong historical performance, current market conditions and company fundamentals are leading to its decline.